Global Pharmacokinetics Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 16-Jul-2021
No. of pages: 108
Inquire Before Buying

Pharmacokinetics is a branch of pharmacology dedicated to determining the fate of substances administered to a living organism.

Pharmacokinetics describes how the body affects a specific chemical after administration through the mechanisms of absorption and distribution, as well as the metabolic changes of the substance in the body, and the effects and routes of excretion of the metabolites of the drug.

Market Analysis and Insights: Global Pharmacokinetics Market

The global Pharmacokinetics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pharmacokinetics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pharmacokinetics market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pharmacokinetics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pharmacokinetics market.

Global Pharmacokinetics Scope and Market Size

Pharmacokinetics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pharmacokinetics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Noncompartmental Methods

- Compartmental Methods

Segment by Application

- Oncology

- Cardiovascular Diseases

- Infectious Diseases

- Autoimmune Diseases

- Respiratory Disorders

- Neurological Disorders

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Charles River Laboratories

- Covance

- Cyprotex

- Drumetix Laboratories

- Eurofins Scientific

- GVK Biosciences

- LGC

- Parexel

- Pharmoptima

- TCG Lifesciences

Global Pharmacokinetics Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmacokinetics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Noncompartmental Methods
1.2.3 Compartmental Methods
1.3 Market by Application
1.3.1 Global Pharmacokinetics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Oncology
1.3.3 Cardiovascular Diseases
1.3.4 Infectious Diseases
1.3.5 Autoimmune Diseases
1.3.6 Respiratory Disorders
1.3.7 Neurological Disorders
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pharmacokinetics Market Perspective (2016-2027)
2.2 Pharmacokinetics Growth Trends by Regions
2.2.1 Pharmacokinetics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pharmacokinetics Historic Market Share by Regions (2016-2021)
2.2.3 Pharmacokinetics Forecasted Market Size by Regions (2022-2027)
2.3 Pharmacokinetics Industry Dynamic
2.3.1 Pharmacokinetics Market Trends
2.3.2 Pharmacokinetics Market Drivers
2.3.3 Pharmacokinetics Market Challenges
2.3.4 Pharmacokinetics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmacokinetics Players by Revenue
3.1.1 Global Top Pharmacokinetics Players by Revenue (2016-2021)
3.1.2 Global Pharmacokinetics Revenue Market Share by Players (2016-2021)
3.2 Global Pharmacokinetics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pharmacokinetics Revenue
3.4 Global Pharmacokinetics Market Concentration Ratio
3.4.1 Global Pharmacokinetics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmacokinetics Revenue in 2020
3.5 Pharmacokinetics Key Players Head office and Area Served
3.6 Key Players Pharmacokinetics Product Solution and Service
3.7 Date of Enter into Pharmacokinetics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmacokinetics Breakdown Data by Type
4.1 Global Pharmacokinetics Historic Market Size by Type (2016-2021)
4.2 Global Pharmacokinetics Forecasted Market Size by Type (2022-2027)
5 Pharmacokinetics Breakdown Data by Application
5.1 Global Pharmacokinetics Historic Market Size by Application (2016-2021)
5.2 Global Pharmacokinetics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Pharmacokinetics Market Size (2016-2027)
6.2 North America Pharmacokinetics Market Size by Type
6.2.1 North America Pharmacokinetics Market Size by Type (2016-2021)
6.2.2 North America Pharmacokinetics Market Size by Type (2022-2027)
6.2.3 North America Pharmacokinetics Market Size by Type (2016-2027)
6.3 North America Pharmacokinetics Market Size by Application
6.3.1 North America Pharmacokinetics Market Size by Application (2016-2021)
6.3.2 North America Pharmacokinetics Market Size by Application (2022-2027)
6.3.3 North America Pharmacokinetics Market Size by Application (2016-2027)
6.4 North America Pharmacokinetics Market Size by Country
6.4.1 North America Pharmacokinetics Market Size by Country (2016-2021)
6.4.2 North America Pharmacokinetics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Pharmacokinetics Market Size (2016-2027)
7.2 Europe Pharmacokinetics Market Size by Type
7.2.1 Europe Pharmacokinetics Market Size by Type (2016-2021)
7.2.2 Europe Pharmacokinetics Market Size by Type (2022-2027)
7.2.3 Europe Pharmacokinetics Market Size by Type (2016-2027)
7.3 Europe Pharmacokinetics Market Size by Application
7.3.1 Europe Pharmacokinetics Market Size by Application (2016-2021)
7.3.2 Europe Pharmacokinetics Market Size by Application (2022-2027)
7.3.3 Europe Pharmacokinetics Market Size by Application (2016-2027)
7.4 Europe Pharmacokinetics Market Size by Country
7.4.1 Europe Pharmacokinetics Market Size by Country (2016-2021)
7.4.2 Europe Pharmacokinetics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Pharmacokinetics Market Size (2016-2027)
8.2 Asia-Pacific Pharmacokinetics Market Size by Type
8.2.1 Asia-Pacific Pharmacokinetics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pharmacokinetics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pharmacokinetics Market Size by Type (2016-2027)
8.3 Asia-Pacific Pharmacokinetics Market Size by Application
8.3.1 Asia-Pacific Pharmacokinetics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pharmacokinetics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pharmacokinetics Market Size by Application (2016-2027)
8.4 Asia-Pacific Pharmacokinetics Market Size by Region
8.4.1 Asia-Pacific Pharmacokinetics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pharmacokinetics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Pharmacokinetics Market Size (2016-2027)
9.2 Latin America Pharmacokinetics Market Size by Type
9.2.1 Latin America Pharmacokinetics Market Size by Type (2016-2021)
9.2.2 Latin America Pharmacokinetics Market Size by Type (2022-2027)
9.2.3 Latin America Pharmacokinetics Market Size by Type (2016-2027)
9.3 Latin America Pharmacokinetics Market Size by Application
9.3.1 Latin America Pharmacokinetics Market Size by Application (2016-2021)
9.3.2 Latin America Pharmacokinetics Market Size by Application (2022-2027)
9.3.3 Latin America Pharmacokinetics Market Size by Application (2016-2027)
9.4 Latin America Pharmacokinetics Market Size by Country
9.4.1 Latin America Pharmacokinetics Market Size by Country (2016-2021)
9.4.2 Latin America Pharmacokinetics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmacokinetics Market Size (2016-2027)
10.2 Middle East & Africa Pharmacokinetics Market Size by Type
10.2.1 Middle East & Africa Pharmacokinetics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pharmacokinetics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pharmacokinetics Market Size by Type (2016-2027)
10.3 Middle East & Africa Pharmacokinetics Market Size by Application
10.3.1 Middle East & Africa Pharmacokinetics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pharmacokinetics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pharmacokinetics Market Size by Application (2016-2027)
10.4 Middle East & Africa Pharmacokinetics Market Size by Country
10.4.1 Middle East & Africa Pharmacokinetics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pharmacokinetics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Charles River Laboratories
11.1.1 Charles River Laboratories Company Details
11.1.2 Charles River Laboratories Business Overview
11.1.3 Charles River Laboratories Pharmacokinetics Introduction
11.1.4 Charles River Laboratories Revenue in Pharmacokinetics Business (2016-2021)
11.1.5 Charles River Laboratories Recent Development
11.2 Covance
11.2.1 Covance Company Details
11.2.2 Covance Business Overview
11.2.3 Covance Pharmacokinetics Introduction
11.2.4 Covance Revenue in Pharmacokinetics Business (2016-2021)
11.2.5 Covance Recent Development
11.3 Cyprotex
11.3.1 Cyprotex Company Details
11.3.2 Cyprotex Business Overview
11.3.3 Cyprotex Pharmacokinetics Introduction
11.3.4 Cyprotex Revenue in Pharmacokinetics Business (2016-2021)
11.3.5 Cyprotex Recent Development
11.4 Drumetix Laboratories
11.4.1 Drumetix Laboratories Company Details
11.4.2 Drumetix Laboratories Business Overview
11.4.3 Drumetix Laboratories Pharmacokinetics Introduction
11.4.4 Drumetix Laboratories Revenue in Pharmacokinetics Business (2016-2021)
11.4.5 Drumetix Laboratories Recent Development
11.5 Eurofins Scientific
11.5.1 Eurofins Scientific Company Details
11.5.2 Eurofins Scientific Business Overview
11.5.3 Eurofins Scientific Pharmacokinetics Introduction
11.5.4 Eurofins Scientific Revenue in Pharmacokinetics Business (2016-2021)
11.5.5 Eurofins Scientific Recent Development
11.6 GVK Biosciences
11.6.1 GVK Biosciences Company Details
11.6.2 GVK Biosciences Business Overview
11.6.3 GVK Biosciences Pharmacokinetics Introduction
11.6.4 GVK Biosciences Revenue in Pharmacokinetics Business (2016-2021)
11.6.5 GVK Biosciences Recent Development
11.7 LGC
11.7.1 LGC Company Details
11.7.2 LGC Business Overview
11.7.3 LGC Pharmacokinetics Introduction
11.7.4 LGC Revenue in Pharmacokinetics Business (2016-2021)
11.7.5 LGC Recent Development
11.8 Parexel
11.8.1 Parexel Company Details
11.8.2 Parexel Business Overview
11.8.3 Parexel Pharmacokinetics Introduction
11.8.4 Parexel Revenue in Pharmacokinetics Business (2016-2021)
11.8.5 Parexel Recent Development
11.9 Pharmoptima
11.9.1 Pharmoptima Company Details
11.9.2 Pharmoptima Business Overview
11.9.3 Pharmoptima Pharmacokinetics Introduction
11.9.4 Pharmoptima Revenue in Pharmacokinetics Business (2016-2021)
11.9.5 Pharmoptima Recent Development
11.10 TCG Lifesciences
11.10.1 TCG Lifesciences Company Details
11.10.2 TCG Lifesciences Business Overview
11.10.3 TCG Lifesciences Pharmacokinetics Introduction
11.10.4 TCG Lifesciences Revenue in Pharmacokinetics Business (2016-2021)
11.10.5 TCG Lifesciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Pharmacokinetics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Noncompartmental Methods
Table 3. Key Players of Compartmental Methods
Table 4. Global Pharmacokinetics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Pharmacokinetics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Pharmacokinetics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Pharmacokinetics Market Share by Regions (2016-2021)
Table 8. Global Pharmacokinetics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Pharmacokinetics Market Share by Regions (2022-2027)
Table 10. Pharmacokinetics Market Trends
Table 11. Pharmacokinetics Market Drivers
Table 12. Pharmacokinetics Market Challenges
Table 13. Pharmacokinetics Market Restraints
Table 14. Global Pharmacokinetics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Pharmacokinetics Market Share by Players (2016-2021)
Table 16. Global Top Pharmacokinetics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmacokinetics as of 2020)
Table 17. Ranking of Global Top Pharmacokinetics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Pharmacokinetics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Pharmacokinetics Product Solution and Service
Table 21. Date of Enter into Pharmacokinetics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Pharmacokinetics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Pharmacokinetics Revenue Market Share by Type (2016-2021)
Table 25. Global Pharmacokinetics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Pharmacokinetics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Pharmacokinetics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Pharmacokinetics Revenue Market Share by Application (2016-2021)
Table 29. Global Pharmacokinetics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Pharmacokinetics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Pharmacokinetics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Pharmacokinetics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Pharmacokinetics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Pharmacokinetics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Pharmacokinetics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Pharmacokinetics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Pharmacokinetics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Pharmacokinetics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Pharmacokinetics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Pharmacokinetics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Pharmacokinetics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Pharmacokinetics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Pharmacokinetics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Pharmacokinetics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Pharmacokinetics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Pharmacokinetics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Pharmacokinetics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Pharmacokinetics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Pharmacokinetics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Pharmacokinetics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Pharmacokinetics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Pharmacokinetics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Pharmacokinetics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Pharmacokinetics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Pharmacokinetics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Pharmacokinetics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Pharmacokinetics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Pharmacokinetics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Pharmacokinetics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Pharmacokinetics Market Size by Country (2022-2027) & (US$ Million)
Table 61. Charles River Laboratories Company Details
Table 62. Charles River Laboratories Business Overview
Table 63. Charles River Laboratories Pharmacokinetics Product
Table 64. Charles River Laboratories Revenue in Pharmacokinetics Business (2016-2021) & (US$ Million)
Table 65. Charles River Laboratories Recent Development
Table 66. Covance Company Details
Table 67. Covance Business Overview
Table 68. Covance Pharmacokinetics Product
Table 69. Covance Revenue in Pharmacokinetics Business (2016-2021) & (US$ Million)
Table 70. Covance Recent Development
Table 71. Cyprotex Company Details
Table 72. Cyprotex Business Overview
Table 73. Cyprotex Pharmacokinetics Product
Table 74. Cyprotex Revenue in Pharmacokinetics Business (2016-2021) & (US$ Million)
Table 75. Cyprotex Recent Development
Table 76. Drumetix Laboratories Company Details
Table 77. Drumetix Laboratories Business Overview
Table 78. Drumetix Laboratories Pharmacokinetics Product
Table 79. Drumetix Laboratories Revenue in Pharmacokinetics Business (2016-2021) & (US$ Million)
Table 80. Drumetix Laboratories Recent Development
Table 81. Eurofins Scientific Company Details
Table 82. Eurofins Scientific Business Overview
Table 83. Eurofins Scientific Pharmacokinetics Product
Table 84. Eurofins Scientific Revenue in Pharmacokinetics Business (2016-2021) & (US$ Million)
Table 85. Eurofins Scientific Recent Development
Table 86. GVK Biosciences Company Details
Table 87. GVK Biosciences Business Overview
Table 88. GVK Biosciences Pharmacokinetics Product
Table 89. GVK Biosciences Revenue in Pharmacokinetics Business (2016-2021) & (US$ Million)
Table 90. GVK Biosciences Recent Development
Table 91. LGC Company Details
Table 92. LGC Business Overview
Table 93. LGC Pharmacokinetics Product
Table 94. LGC Revenue in Pharmacokinetics Business (2016-2021) & (US$ Million)
Table 95. LGC Recent Development
Table 96. Parexel Company Details
Table 97. Parexel Business Overview
Table 98. Parexel Revenue in Pharmacokinetics Business (2016-2021) & (US$ Million)
Table 99. Parexel Recent Development
Table 100. Pharmoptima Company Details
Table 101. Pharmoptima Business Overview
Table 102. Pharmoptima Pharmacokinetics Product
Table 103. Pharmoptima Revenue in Pharmacokinetics Business (2016-2021) & (US$ Million)
Table 104. Pharmoptima Recent Development
Table 105. TCG Lifesciences Company Details
Table 106. TCG Lifesciences Business Overview
Table 107. TCG Lifesciences Pharmacokinetics Product
Table 108. TCG Lifesciences Revenue in Pharmacokinetics Business (2016-2021) & (US$ Million)
Table 109. TCG Lifesciences Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmacokinetics Market Share by Type: 2020 VS 2027
Figure 2. Noncompartmental Methods Features
Figure 3. Compartmental Methods Features
Figure 4. Global Pharmacokinetics Market Share by Application: 2020 VS 2027
Figure 5. Oncology Case Studies
Figure 6. Cardiovascular Diseases Case Studies
Figure 7. Infectious Diseases Case Studies
Figure 8. Autoimmune Diseases Case Studies
Figure 9. Respiratory Disorders Case Studies
Figure 10. Neurological Disorders Case Studies
Figure 11. Others Case Studies
Figure 12. Pharmacokinetics Report Years Considered
Figure 13. Global Pharmacokinetics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Pharmacokinetics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Pharmacokinetics Market Share by Regions: 2020 VS 2027
Figure 16. Global Pharmacokinetics Market Share by Regions (2022-2027)
Figure 17. Global Pharmacokinetics Market Share by Players in 2020
Figure 18. Global Top Pharmacokinetics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmacokinetics as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Pharmacokinetics Revenue in 2020
Figure 20. Global Pharmacokinetics Revenue Market Share by Type (2016-2021)
Figure 21. Global Pharmacokinetics Revenue Market Share by Type (2022-2027)
Figure 22. North America Pharmacokinetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Pharmacokinetics Market Share by Type (2016-2027)
Figure 24. North America Pharmacokinetics Market Share by Application (2016-2027)
Figure 25. North America Pharmacokinetics Market Share by Country (2016-2027)
Figure 26. United States Pharmacokinetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Pharmacokinetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Pharmacokinetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Pharmacokinetics Market Share by Type (2016-2027)
Figure 30. Europe Pharmacokinetics Market Share by Application (2016-2027)
Figure 31. Europe Pharmacokinetics Market Share by Country (2016-2027)
Figure 32. Germany Pharmacokinetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Pharmacokinetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Pharmacokinetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Pharmacokinetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Pharmacokinetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Pharmacokinetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Pharmacokinetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Pharmacokinetics Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Pharmacokinetics Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Pharmacokinetics Market Share by Region (2016-2027)
Figure 42. China Pharmacokinetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Pharmacokinetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Pharmacokinetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Pharmacokinetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Pharmacokinetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Pharmacokinetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Pharmacokinetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Pharmacokinetics Market Share by Type (2016-2027)
Figure 50. Latin America Pharmacokinetics Market Share by Application (2016-2027)
Figure 51. Latin America Pharmacokinetics Market Share by Country (2016-2027)
Figure 52. Mexico Pharmacokinetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Pharmacokinetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Pharmacokinetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Pharmacokinetics Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Pharmacokinetics Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Pharmacokinetics Market Share by Country (2016-2027)
Figure 58. Turkey Pharmacokinetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Pharmacokinetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Pharmacokinetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Charles River Laboratories Revenue Growth Rate in Pharmacokinetics Business (2016-2021)
Figure 62. Covance Revenue Growth Rate in Pharmacokinetics Business (2016-2021)
Figure 63. Cyprotex Revenue Growth Rate in Pharmacokinetics Business (2016-2021)
Figure 64. Drumetix Laboratories Revenue Growth Rate in Pharmacokinetics Business (2016-2021)
Figure 65. Eurofins Scientific Revenue Growth Rate in Pharmacokinetics Business (2016-2021)
Figure 66. GVK Biosciences Revenue Growth Rate in Pharmacokinetics Business (2016-2021)
Figure 67. LGC Revenue Growth Rate in Pharmacokinetics Business (2016-2021)
Figure 68. Parexel Revenue Growth Rate in Pharmacokinetics Business (2016-2021)
Figure 69. Pharmoptima Revenue Growth Rate in Pharmacokinetics Business (2016-2021)
Figure 70. TCG Lifesciences Revenue Growth Rate in Pharmacokinetics Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs